Mayo Clinic

UIAA Medical Commission Recommendations for Mountaineers, Hillwalkers, Trekkers, and Rock and Ice Climbers with Diabetes (2023) Hillebrandt D, Gurtoo A, Kupper T, Richards P, Schöffl V, Shah P, van der Spek R, et al. Journal article p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study (2023) Köbel M, Kang EY, Weir A, Rambau PF, Lee CH, Nelson GS, Ghatage P, et al. Journal article, Original article Flares after COVID-19 infection in patients with idiopathic inflammatory myopathies: results from the COVAD study (2023) Ali SS, Naveen R, Sen P, Day J, Joshi M, Nune A, Nikiphorou E, et al. Journal article Systemic sclerosis and COVID-19 vaccine safety: short-term insights from the global COVID-19 vaccination in autoimmune disease (COVAD) survey (2023) Naveen R, Thakare D, Kuwana M, Pauling J, Day J, Joshi M, Parodis I, et al. Journal article Position statement and updated international guideline for safe and effective whole-body electromyostimulation training-the need for common sense in WB-EMS application (2023) Kemmler W, Froehlich M, Ludwig O, Eifler C, von Stengel S, Willert S, Teschler M, et al. Journal article Performing Automatic Identification and Staging of Urothelial Carcinoma in Bladder Cancer Patients Using a Hybrid Deep-Machine Learning Approach (2023) Sarkar S, Min K, Ikram W, Tatton RW, Riaz IB, Silva AC, Bryce AH, et al. Journal article CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study (2023) Kang EY, Weir A, Meagher NS, Farrington K, Nelson GS, Ghatage P, Lee CH, et al. Journal article Continued progress in DICOM neurophysiology standardization (2023) Halford JJ, Brinkmann BH, Clunie DA, Gotman J, Beniczky S, Rampp S, Rémi J, et al. Journal article Vaccine hesitancy decreases in rheumatic diseases, long-term concerns remain in myositis: a comparative analysis of the COVAD surveys (2023) Sen P, Naveen R, Houshmand N, Kia SM, Joshi M, Saha S, Jagtap K, et al. Journal article Effective treatment of low-risk acute GVHD with itacitinib monotherapy (2023) Etra A, Capellini A, Alousi A, Al Malki MM, Choe H, DeFilipp Z, Hogan WJ, et al. Journal article